Source: Eur Respir J 2002; 19: 525-529
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Huang X.L., El Kebir D., De Buys Roessingh A.S., Schneider J.C., Jacob L., Mercier J.C., Dall'Ava-Santucci J., Dinh-Xuan A.T.. Role of tyrosine phosphatase in the modulation of pulmonary vascular tone. Eur Respir J 2002; 19: 525-529

Member's Comments

No comment yet.

Related content which might interest you: New drugs for pulmonary hypertension Source: Eur Respir Mon 2012; 57: 233-246 Year: 2012 Increased Rho-kinase expression and activity and pulmonary endothelial dysfunction in smokers with normal lung function Source: Eur Respir J 2011; 37: 349 Year: 2011 Platelet-activating factor reduces endothelial nitric oxide production: role of acid sphingomyelinase Source: Eur Respir J 2010; 36: 417 Year: 2010 Regulation of eosinophil apoptosis by nitric oxide: role of JNK and STAT5 Source: Eur Respir J 2003; 22: Suppl. 45, 572s Year: 2003 Src tyrosine kinase is crucial for potassium channel function in human pulmonary arteries Source: Eur Respir J 2013; 41: 85-95 Year: 2013 Inhibition of the glycogen synthase kinase 3β reduces steroid function in human monocytes Source: Annual Congress 2010 - Regulation of airway pharmacology Year: 2010 Looking to the future: a new decade of pulmonary arterial hypertension therapy Source: Eur Respir Rev 2011; 20: 262-269 Year: 2011 Effect of nitric oxide synthase inhibition on airway smooth muscle contraction in mice deficient of the NADPH oxidase subunit p47phox Source: Eur Respir J 2005; 26: Suppl. 49, 224s Year: 2005 Inhibition of glycogen synthase kinase 3beta reduces GC function in human monocytes via modulation of HDAC2 activity Source: Annual Congress 2011 - Models of disease and drug actions Year: 2011 Crucial role for protein kinase C-α and arginase activation in the induction of pulmonary endothelial hyperpermeability by pneumolysin Source: Annual Congress 2010 - Acute lung injury: barrier properties and leukocyte activation Year: 2010 Involvement of human bronchial epithelial cells in proliferation control of T-cells via reversible STAT5 dephosphorylation mediated by nitric oxide (NO) Source: Eur Respir J 2002; 20: Suppl. 38, 207s Year: 2002 MAP kinase phosphatase 1 mediates glucocorticoid inhibition of CD38 expression in human airway smooth muscle Source: Annual Congress 2008 - Basic science in asthma and COPD II Year: 2008 3-Nitrotyrosine inhibits fibroblast-mediated collagen gel contraction and chemotaxis Source: Eur Respir J 2009; 34: 1452-1460 Year: 2009 Regulation of airway smooth muscle RhoA/ROCK activities by cholinergic and bronchodilator stimuli Source: Eur Respir J 2006 Oct 01;28(4):703-711 Year: 2006 The angiogenic integrin a9b1 promotes cell migration through Src-dependent activation of nitric oxide synthesis Source: Annual Congress 2009 - What is new in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease? Year: 2009 Expression of endothelial nitric oxide synthase (eNOS) and endothelin-1 (ET-1) in pulmonary arteries of patients with severe COPD Source: Annual Congress 2003 - Pathophysiology of the pulmonary circulation Year: 2003 Endothelin-1 inhibits TASK-1 in human pulmonary artery smooth muscle cells via phospholipase C-diacylglycerol-protein kinase C-pathway Source: Annual Congress 2008 - Pathophysiology of pulmonary hypertension Year: 2008 Effects of endothelial nitric oxide synthase enzyme, angiotensin converting enzyme and serotonin transporter genotypes on pulmonary hypertension in COPD Source: Annual Congress 2010 - Pulmonary circulation I Year: 2010 FTY720-induced human pulmonary endothelial barrier enhancement is mediated by c-Abl Source: Eur Respir J 2011; 37: 78-88 Year: 2011 Upregulation of nitric oxide synthase, cyclooxygenase, and heme oxygenase blunts the hypoxia-elicited polmonary microvessel response in ischemia-reperfusion lung injury Source: Eur Respir J 2002; 20: Suppl. 38, 349s Year: 2002